脂肪性-话题@MedSci

#脂肪性#

235篇内容 | 4202人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1810165, encodeId=0675181016503, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Zydus Cadila的PPAR激动剂saroglitazar在印度获批，用于治疗非酒精性脂肪性肝炎, objectType=article, longId=189572, objectId=17961895e2f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=17961895e2f5, replyNumber=0, likeNumber=0, createdTime=2020-09-28, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=17961895e2f5, moduleTitle=Zydus Cadila的PPAR激动剂saroglitazar在印度获批，用于治疗非酒精性脂肪性肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=17961895e2f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810189, encodeId=092c18101894f, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Hepatology: 肝功能不全患者缺乏肝再生蛋白会促进非酒精性脂肪性肝炎和纤维化的发生, objectType=article, longId=203256, objectId=af3e20325689, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af3e20325689, replyNumber=0, likeNumber=76, createdTime=2020-12-01, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af3e20325689, moduleTitle=Hepatology: 肝功能不全患者缺乏肝再生蛋白会促进非酒精性脂肪性肝炎和纤维化的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af3e20325689)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810162, encodeId=3beb181016210, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=AP&T：严重肥胖和非酒精性脂肪性肝炎患者的血浆代谢改变情况, objectType=article, longId=188220, objectId=dd2e18822005, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd2e18822005, replyNumber=0, likeNumber=58, createdTime=2020-04-17, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd2e18822005, moduleTitle=AP&T：严重肥胖和非酒精性脂肪性肝炎患者的血浆代谢改变情况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd2e18822005)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810190, encodeId=5b66181019094, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=FDA批准候选药物lanifibranor进入III期临床，以治疗非酒精性脂肪性肝炎（NASH）, objectType=article, longId=203274, objectId=cfcb2032e4c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfcb2032e4c1, replyNumber=0, likeNumber=61, createdTime=2021-05-06, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfcb2032e4c1, moduleTitle=FDA批准候选药物lanifibranor进入III期临床，以治疗非酒精性脂肪性肝炎（NASH）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfcb2032e4c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810163, encodeId=a85f18101633d, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J Hepatology： IL-17在脂肪性肝细胞和巨噬细胞中促进酒精相关性肝病中的肝细胞癌的发生, objectType=article, longId=188602, objectId=0572188602fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0572188602fa, replyNumber=0, likeNumber=75, createdTime=2021-01-02, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0572188602fa, moduleTitle=J Hepatology： IL-17在脂肪性肝细胞和巨噬细胞中促进酒精相关性肝病中的肝细胞癌的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0572188602fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810179, encodeId=da0718101e903, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Hepatology: Kupffer细胞中的YAP促进非酒精性脂肪性肝炎的进展, objectType=article, longId=197928, objectId=011419e928bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=011419e928bb, replyNumber=0, likeNumber=75, createdTime=2020-10-07, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=011419e928bb, moduleTitle=Hepatology: Kupffer细胞中的YAP促进非酒精性脂肪性肝炎的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=011419e928bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810166, encodeId=e8dd181016650, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J Gastroenterology：身体代谢情况与非酒精性脂肪性肝炎与严重纤维化之间的关联 , objectType=article, longId=189575, objectId=4cba1895e540, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4cba1895e540, replyNumber=0, likeNumber=95, createdTime=2020-08-18, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4cba1895e540, moduleTitle=J Gastroenterology：身体代谢情况与非酒精性脂肪性肝炎与严重纤维化之间的关联 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4cba1895e540)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810159, encodeId=4367181015902, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J Hepatology：法尼醇X受体激动剂对非酒精性脂肪性肝炎患者脂蛋白谱的影响, objectType=article, longId=186945, objectId=51681869456c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51681869456c, replyNumber=0, likeNumber=0, createdTime=2020-06-01, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51681869456c, moduleTitle=J Hepatology：法尼醇X受体激动剂对非酒精性脂肪性肝炎患者脂蛋白谱的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=51681869456c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810185, encodeId=0a4e18101850a, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Hepatology: 白细胞介素22可以通过改善嗜中性粒细胞驱动性非酒精性脂肪性肝炎的炎症程度, objectType=article, longId=200471, objectId=d64c2004e17a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d64c2004e17a, replyNumber=0, likeNumber=67, createdTime=2021-01-21, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d64c2004e17a, moduleTitle=Hepatology: 白细胞介素22可以通过改善嗜中性粒细胞驱动性非酒精性脂肪性肝炎的炎症程度, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d64c2004e17a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810173, encodeId=7ea518101e3c6, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=非酒精性脂肪性肝病改名了！代谢相关脂肪性肝病国际专家共识发布, objectType=article, longId=194341, objectId=4ced19434166, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ced19434166, replyNumber=0, likeNumber=125, createdTime=2020-08-14, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ced19434166, moduleTitle=非酒精性脂肪性肝病改名了！代谢相关脂肪性肝病国际专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ced19434166)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810186, encodeId=b62b181018684, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Cell:中山大学苏士成/许小丁/高志良发现表观遗传对于非酒精性脂肪性肝炎的关键调控作用, objectType=article, longId=200761, objectId=c493200e6155, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c493200e6155, replyNumber=0, likeNumber=73, createdTime=2021-05-31, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c493200e6155, moduleTitle=Cell:中山大学苏士成/许小丁/高志良发现表观遗传对于非酒精性脂肪性肝炎的关键调控作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c493200e6155)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810182, encodeId=cc6f18101828b, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性, objectType=article, longId=199610, objectId=27e819961026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27e819961026, replyNumber=0, likeNumber=43, createdTime=2020-11-29, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27e819961026, moduleTitle=Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27e819961026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810178, encodeId=40fc18101e803, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J Hepatol：妊娠期非酒精性脂肪性肝病与孕产妇及围产期不良结局相关, objectType=article, longId=197741, objectId=156e19e741ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=156e19e741ff, replyNumber=0, likeNumber=56, createdTime=2020-11-03, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=156e19e741ff, moduleTitle=J Hepatol：妊娠期非酒精性脂肪性肝病与孕产妇及围产期不良结局相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=156e19e741ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810169, encodeId=7532181016924, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=A3腺苷受体激动剂Namodenoson，治疗非酒精性脂肪性肝炎（NASH）的II期研究成功, objectType=article, longId=191736, objectId=e771191e364a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e771191e364a, replyNumber=0, likeNumber=0, createdTime=2020-11-01, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e771191e364a, moduleTitle=A3腺苷受体激动剂Namodenoson，治疗非酒精性脂肪性肝炎（NASH）的II期研究成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e771191e364a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810167, encodeId=fa47181016e68, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Lancet：非酒精性脂肪性肝、非酒精性脂肪性肝炎以及肝纤维化的鉴别新机制, objectType=article, longId=190440, objectId=aeda1904409e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=aeda1904409e, replyNumber=0, likeNumber=163, createdTime=2020-10-07, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=aeda1904409e, moduleTitle=Lancet：非酒精性脂肪性肝、非酒精性脂肪性肝炎以及肝纤维化的鉴别新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=aeda1904409e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810183, encodeId=d7801810183a2, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J Hepatol: Maddrey评分<32分且病理提示存在脂肪性肝炎的酒精性肝病患者长期预后特点, objectType=article, longId=199716, objectId=2d7d199e16c8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2d7d199e16c8, replyNumber=0, likeNumber=75, createdTime=2021-06-30, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2d7d199e16c8, moduleTitle=J Hepatol: Maddrey评分<32分且病理提示存在脂肪性肝炎的酒精性肝病患者长期预后特点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2d7d199e16c8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810158, encodeId=403a181015855, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=Northsea Therapeutics融资4000万美元开发鱼油衍生物，治疗非酒精性脂肪性肝炎, objectType=article, longId=186009, objectId=83751860095e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=83751860095e, replyNumber=0, likeNumber=81, createdTime=2020-04-18, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=83751860095e, moduleTitle=Northsea Therapeutics融资4000万美元开发鱼油衍生物，治疗非酒精性脂肪性肝炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=83751860095e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810150, encodeId=5941181015052, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=脂肪性肝病诊疗规范化的专家建议（2019 年修订版）, objectType=article, longId=182796, objectId=b3b1182e9660, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b3b1182e9660, replyNumber=0, likeNumber=0, createdTime=2020-02-23, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b3b1182e9660, moduleTitle=脂肪性肝病诊疗规范化的专家建议（2019 年修订版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b3b1182e9660)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810155, encodeId=126b18101557a, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=J hepatology：奥贝胆酸对非酒精性脂肪性肝炎患者脂蛋白谱的影响, objectType=article, longId=185404, objectId=6f5918540456, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f5918540456, replyNumber=0, likeNumber=103, createdTime=2020-10-20, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f5918540456, moduleTitle=J hepatology：奥贝胆酸对非酒精性脂肪性肝炎患者脂蛋白谱的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6f5918540456)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1810175, encodeId=165e18101e5de, content=<a href='/topic/show?id=70f484349b5' target=_blank style='color:#2F92EE;'>#脂肪性#</a>, objectTitle=非酒精性脂肪性肝炎（NASH）：歌礼生物的ASC40显著降低肝脏脂肪，响应率达61％, objectType=article, longId=196200, objectId=2de719620026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2de719620026, replyNumber=0, likeNumber=69, createdTime=2021-04-21, rootId=0, userName=qjddjq, userId=c49e75, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2de719620026, moduleTitle=非酒精性脂肪性肝炎（NASH）：歌礼生物的ASC40显著降低肝脏脂肪，响应率达61％, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2de719620026)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

脂肪性

2020-05-29

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Zydus Cadila的PPAR激动剂saroglitazar在印度获批，用于治疗非酒精性脂肪性肝炎

2020-09-28

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Hepatology: 肝功能不全患者缺乏肝再生蛋白会促进非酒精性脂肪性肝炎和纤维化的发生

2020-12-01

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

AP&T：严重肥胖和非酒精性脂肪性肝炎患者的血浆代谢改变情况

2020-04-17

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

FDA批准候选药物lanifibranor进入III期临床，以治疗非酒精性脂肪性肝炎（NASH）

2021-05-06

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J Hepatology： IL-17在脂肪性肝细胞和巨噬细胞中促进酒精相关性肝病中的肝细胞癌的发生

2021-01-02

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Hepatology: Kupffer细胞中的YAP促进非酒精性脂肪性肝炎的进展

2020-10-07

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J Gastroenterology：身体代谢情况与非酒精性脂肪性肝炎与严重纤维化之间的关联

2020-08-18

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J Hepatology：法尼醇X受体激动剂对非酒精性脂肪性肝炎患者脂蛋白谱的影响

2020-06-01

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Hepatology: 白细胞介素22可以通过改善嗜中性粒细胞驱动性非酒精性脂肪性肝炎的炎症程度

2021-01-21

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

非酒精性脂肪性肝病改名了！代谢相关脂肪性肝病国际专家共识发布

2020-08-14

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Cell:中山大学苏士成/许小丁/高志良发现表观遗传对于非酒精性脂肪性肝炎的关键调控作用

2021-05-31

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性

2020-11-29

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J Hepatol：妊娠期非酒精性脂肪性肝病与孕产妇及围产期不良结局相关

2020-11-03

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

A3腺苷受体激动剂Namodenoson，治疗非酒精性脂肪性肝炎（NASH）的II期研究成功

2020-11-01

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Lancet：非酒精性脂肪性肝、非酒精性脂肪性肝炎以及肝纤维化的鉴别新机制

2020-10-07

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J Hepatol: Maddrey评分<32分且病理提示存在脂肪性肝炎的酒精性肝病患者长期预后特点

2021-06-30

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

Northsea Therapeutics融资4000万美元开发鱼油衍生物，治疗非酒精性脂肪性肝炎

2020-04-18

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

脂肪性肝病诊疗规范化的专家建议（2019 年修订版）

2020-02-23

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

J hepatology：奥贝胆酸对非酒精性脂肪性肝炎患者脂蛋白谱的影响

2020-10-20

qjddjq (审核中...)

前往app查看评论内容

#脂肪性#

非酒精性脂肪性肝炎（NASH）：歌礼生物的ASC40显著降低肝脏脂肪，响应率达61％

2021-04-21

科室
- - 订阅+
  - 更多科室
工具
服务